In the last trading session, 1.98 million shares of the AIkido Pharma Inc. (NASDAQ:AIKI) were traded, and its beta was 1.56. Most recently the company’s share price was $0.36, and it changed around $0.01 or 2.95% from the last close, which brings the market valuation of the company to $31.20M. AIKI currently trades at a discount to its 52-week high of $1.21, offering almost -236.11% off that amount. The share price’s 52-week low was $0.30, which indicates that the current value has risen by an impressive 16.67% since then. We note from AIkido Pharma Inc.’s average daily trading volume that its 10-day average is 3.72 million shares, with the 3-month average coming to 1.52 million.
AIkido Pharma Inc. stock received a consensus recommendation rating of a Buy, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended AIKI as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. AIkido Pharma Inc. is expected to report earnings per share of -$0.01 for the current quarter.
Instantly AIKI has showed a green trend with a performance of 2.95% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.5800 on Friday, 05/06/22 increased the stock’s daily price by 37.93%. The company’s shares are currently down -38.67% year-to-date, but still up 9.36% over the last five days. On the other hand, AIkido Pharma Inc. (NASDAQ:AIKI) is -14.69% up in the 30-day period. We can see from the shorts that 0.69 million shares have been sold at a short interest cover period of 0.64 day(s).
The consensus price target as assigned by Wall Street analysts is $2.00, which translates to bulls needing to increase their stock price by 82.0% from its current value. Analyst projections state that AIKI is forecast to be at a low of $2.00 and a high of $2.00. In order for the stock price to hit the forecast high, the stock would need to plunge -455.56% from its current level, while the stock would need to crash -455.56% from its current level to reach the projected low.
AIkido Pharma Inc. (AIKI) estimates and forecasts
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -14.90%.
AIkido Pharma Inc.’s next quarterly earnings report is expected to be released around March 23 and March 28.
AIkido Pharma Inc. (NASDAQ:AIKI)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.20% of AIkido Pharma Inc. shares, and 10.69% of them are in the hands of institutional investors. The stock currently has a share float of 10.72%. AIkido Pharma Inc. stock is held by 25 institutions, with Vanguard Group, Inc. (The) being the largest institutional investor. By Dec 30, 2021, it held 4.60% of the shares, which is about 4.13 million shares worth $2.42 million.
Blackrock Inc., with 1.43% or 1.28 million shares worth $0.75 million as of Dec 30, 2021, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 30, 2021. The former held 2.69 million shares worth $1.58 million, making up 2.99% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 1.32 million shares worth around $0.78 million, which represents about 1.48% of the total shares outstanding.